Allen Dale Biosciences

BEFIX-O Cefixime 200mg and Ofloxacin 200mg Tablets are widely used for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, gastrointestinal infections, typhoid fever, throat infections, bronchitis, sinusitis, and skin infections. This broad-spectrum antibiotic combination helps fight Gram-positive and Gram-negative bacteria effectively, reduce infection symptoms, and support faster recovery from moderate to severe bacterial infections. BEFIX-O Tablets are manufactured under strict pharmaceutical quality standards and are suitable for hospitals, clinics, pharmacies, and PCD pharma franchise business requirements. 

BEFIX-CV Tablets containing Cefixime 200 mg + Clavulanic Acid 125 mg is a highly effective broad-spectrum antibiotic medicine used for the treatment of bacterial infections, respiratory tract infections, ENT infections, urinary tract infections (UTI), bronchitis, tonsillitis, sinusitis, throat infection, ear infection, and skin infections. Cefixime is a powerful third-generation cephalosporin antibiotic that helps eliminate infection-causing bacteria, while Clavulanic Acid acts as a beta-lactamase inhibitor, enhancing antibiotic effectiveness against resistant bacterial strains. This combination provides reliable treatment for upper and lower respiratory infections, fever associated with bacterial infections, and recurrent infectious conditions. BEFIX-CV is widely prescribed in the general medicine and anti-infective therapy segment for effective bacterial infection management. The product is highly demanded in the pharmaceutical PCD franchise, hospital supply, third-party manufacturing, and export market in India, making it a trusted formulation in the antibiotic and anti-infective category.

KDLOXIN OZ Ofloxacin 200 mg + Ornidazole 500 mg Tablets is a highly effective broad-spectrum anti-infective and antibacterial-antiprotozoal combination medicine used for the treatment of bacterial infections, gastrointestinal infections, diarrhea, dysentery, amoebiasis, food poisoning, urinary tract infections (UTI), pelvic infections, and mixed infections. Ofloxacin is a powerful fluoroquinolone antibiotic that helps eliminate infection-causing bacteria, while Ornidazole is an antiprotozoal and antibacterial agent that is effective against anaerobic bacteria and protozoal infections, providing complete infection control and faster recovery. This combination is widely prescribed for loose motion with infection, stomach infection, and intestinal bacterial imbalance. KDLOXIN OZ is highly demanded in the pharmaceutical PCD franchise, anti-infective range, hospital supply, third-party manufacturing, and export market in India, making it a trusted formulation in the antibiotic and gastrointestinal infection treatment segment.

TPOXIM 250 Cefuroxime 250mg Tablets are widely used for the treatment of bacterial infections such as respiratory tract infections, throat infections, sinusitis, bronchitis, pneumonia, urinary tract infections, skin infections, ear infections, and soft tissue infections. This broad-spectrum antibiotic tablet helps inhibit bacterial growth effectively and supports faster recovery from mild to moderate bacterial infections. TPOXIM 250 Tablets are manufactured under strict pharmaceutical quality standards and are suitable for hospitals, clinics, pharmacies, and PCD pharma franchise business requirements.

ADPOXIME-CV Tablet (Cefpodoxime Proxetil 200 mg + Clavulanic Acid 125 mg, ALU-ALU Pack 10x6) is a powerful broad-spectrum antibiotic combination indicated for the treatment of various resistant bacterial infections. This combination enhances antibacterial efficacy, where Cefpodoxime Proxetil 200 mg inhibits bacterial cell wall synthesis and Clavulanic Acid 125 mg acts as a beta-lactamase inhibitor, overcoming resistance. It is widely prescribed for respiratory tract infections such as pneumonia, bronchitis, and sinusitis, ENT infections including tonsillitis, pharyngitis, and otitis media, as well as urinary tract infections (UTIs), skin and soft tissue infections, and certain gynecological infections. Due to its enhanced action against resistant strains, ADPOXIME-CV uses in India are increasing for antibiotic-resistant infections, making it a preferred choice for UTI treatment, respiratory infection antibiotics, and cephalosporin with clavulanic acid tablets, offering faster recovery, improved clinical outcomes, and better patient compliance.

ADZITHRO 250 Azithromycin 250 mg Tablets is a highly effective broad-spectrum macrolide antibiotic medicine used for the treatment of bacterial infections, respiratory tract infections, throat infections, tonsillitis, sinusitis, bronchitis, pneumonia, ear infections, skin infections, and sexually transmitted bacterial infections. Azithromycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and spread of infection-causing bacteria and providing fast relief from fever, sore throat, cough, inflammation, and infection-related symptoms. It is widely prescribed for acute bacterial infections and upper and lower respiratory tract infections due to its broad antimicrobial coverage and convenient dosing schedule. ADZITHRO 250 is highly demanded in the pharmaceutical PCD franchise, anti-infective range, hospital supply, third-party manufacturing, and export market in India, making it a trusted formulation in the antibiotic and infection treatment segment.   

BEFIX-LB Cefixime 200 mg & Lactic Acid Bacillus 60 Million Spores Tablets is a highly effective broad-spectrum antibiotic and probiotic combination medicine used for the treatment of bacterial infections, respiratory tract infections, urinary tract infections (UTI), ENT infections, throat infections, bronchitis, typhoid, gastrointestinal infections, and bacterial diarrhea. Cefixime is a powerful third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, thereby eliminating infection-causing bacteria and providing fast relief from fever, inflammation, and infection-related symptoms. Lactic Acid Bacillus acts as a beneficial probiotic that helps restore healthy intestinal flora, improves digestion, and reduces the risk of antibiotic-associated diarrhea and stomach discomfort during antibiotic therapy. This combination provides effective infection control along with gut health support and better patient tolerance. BEFIX-LB is highly demanded in the pharmaceutical PCD franchise, anti-infective range, hospital supply, third-party manufacturing, and export market in India, making it a trusted formulation in the antibiotic and probiotic therapy segment.